ARAY - Accuray Incorporated
| Previous Close | 4.8100 |
| Open | 4.8400 |
| Bid | 4.85 x 3200 |
| Ask | 5.25 x 3000 |
| Day's Range | 4.8000 - 4.9600 |
| 52 Week Range | 3.1700 - 5.8000 |
| Volume | 623,399 |
| Avg. Volume | 907,727 |
| Market Cap | 433.246M |
| Beta (3Y Monthly) | 1.96 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.27 |
| Earnings Date | Apr 29, 2019 - May 3, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.78 |
- Zacks•5 days ago
Here's Why Investors Should Retain Accuray (ARAY) Stock Now
A series of software upgrades is likely to provide Accuray (ARAY) a competitive edge in the radiation-oncology space.
- Simply Wall St.•11 days ago
When Should You Buy Accuray Incorporated (NASDAQ:ARAY)?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Accuray Incorporated (NASDAQ:ARAY), which is in the Read More...
- GlobeNewswire•16 days ago
Factors of Influence in 2019, Key Indicators and Opportunity within Marathon Oil, Accuray, United Natural Foods, Systemax, Amgen, and NewLink Genetics — New Research Emphasizes Economic Growth
NEW YORK, Feb. 01, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
- Zacks•18 days ago
Varian Strong on Global Expansion and Proton Therapy Arm
Varian's (VAR) strong presence in China instills optimism in the stock.
- Zacks•19 days ago
Accuray & China Isotope Collaborate to Sell Radiation Devices
Management at Accuray (ARAY) sees bright prospects in China.
- Reuters•20 days ago
BRIEF-Accuray And China Isotope And Radiation Corp Enter Joint Venture Contract
Jan 28 (Reuters) - China Isotope & Radiation Corp: * ACCURAY AND CHINA ISOTOPE AND RADIATION CORPORATION ENTER JOINT VENTURE CONTRACT TO MANUFACTURE AND SELL RADIATION ONCOLOGY SYSTEMS IN CHINA * ACCURAY ...
- PR Newswire•20 days ago
Accuray And China Isotope And Radiation Corporation Enter Joint Venture Contract To Manufacture And Sell Radiation Oncology Systems In China
SUNNYVALE, Calif. and TIANJIN, China, Jan. 28, 2019 /PRNewswire/ -- Accuray Asia Limited, a subsidiary of Accuray Incorporated (ARAY), and CNNC High Energy Equipment (Tianjin) Co., Ltd, a subsidiary of China Isotope and Radiation Corporation (HKSE:01763), today announced the formation of a joint venture ("JV") to manufacture and sell radiation oncology systems in China. Under the terms of the agreement, CIRC's subsidiary will own 51% of the JV and Accuray's subsidiary will own the remaining 49%.
- Thomson Reuters StreetEvents•20 days ago
Edited Transcript of ARAY earnings conference call or presentation 22-Jan-19 9:30pm GMT
Q2 2019 Accuray Inc Earnings Call
- GuruFocus.com•24 days ago
2 Stocks Jump on Wednesday
Procter & Gamble and Accuray move on financial results
- Motley Fool•24 days ago
Why Accuray, Synchrony Financial, and Waters Jumped Today
Market turbulence couldn't stop these stocks from posting sizable gains.
- Motley Fool•25 days ago
Here's Why Accuray Is Flying Higher Today
Traders cheer a mixed earnings report. Here's what investors need to know.
- Zacks•25 days ago
Accuray's (ARAY) Q2 Loss Narrows, Radixact Demand Shoots Up
Demand for flagship Radixact & CyberKnife platforms aids Accuray's (ARAY) fiscal Q2 results.
Motley Fool•25 days agoAccuray Inc (ARAY) Q2 2019 Earnings Conference Call Transcript
ARAY earnings call for the period ending December 31, 2018.
- Associated Press•25 days ago
Accuray: Fiscal 2Q Earnings Snapshot
The Sunnyvale, California-based company said it had a loss of 5 cents per share. The radiation oncology company posted revenue of $102.3 million in the period. Accuray expects full-year revenue in the ...
- PR Newswire•25 days ago
Accuray Reports Fiscal 2019 Second Quarter Results
SUNNYVALE, Calif. , Jan. 22, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the second quarter of fiscal 2019 ended December 31, 2018 . Fiscal Second ...
- Motley Fool•29 days ago
Better Buy: Intuitive Surgical vs. Accuray
The third variable discussed is the most important. And there's no question who the winner is there.
- PR Newswire•last month
The Urology Group Surpasses 1,600 Prostate Cancer Patients Treated with the Accuray CyberKnife® M6™ System
SUNNYVALE, Calif., Jan. 17, 2019 /PRNewswire/ -- According to the American Cancer Society, prostate cancer is the most common cancer in American men other than skin cancer. Accuray Incorporated (ARAY) and The Urology Group (TUG) are partnering to recognize TUG's commitment to improving the lives of men with prostate cancer. TUG physicians recently treated the center's 1,600th prostate cancer patient using the CyberKnife® M6™ System, a groundbreaking radiotherapy device that specializes in delivering stereotactic body radiation therapy (SBRT) treatments with sub-millimeter precision.
- Zacks•last month
Will Accuray (ARAY) Report Negative Earnings Next Week? What You Should Know
Accuray (ARAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- PR Newswire•last month
Accuray To Report Fiscal 2019 Second Quarter Financial Results on January 22, 2019
SUNNYVALE, Calif., Jan. 8, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its second quarter ended December 31, 2018 on Tuesday, January 22, 2019 after the market close. ...
- Simply Wall St.•last month
Read This Before Buying Accuray Incorporated (NASDAQ:ARAY) Shares
We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be remiss not to mention that insider sales have Read More...
- PR Newswire•2 months ago
Accuray to Present at the 37th Annual J.P. Morgan Healthcare Conference on January 9, 2019
SUNNYVALE, Calif. , Jan. 2, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Company will present at the J.P. Morgan 37th Annual Healthcare Conference on Wednesday, January ...
- Insider Monkey•2 months ago
Hedge Funds Are Betting On Accuray Incorporated (ARAY)
The government requires hedge funds and wealthy investors with over a certain portfolio size to file a report that shows their positions at the end of every quarter. Even though it isn’t the intention, these filings level the playing field for ordinary investors. The latest round of 13F filings disclosed the funds’ positions on September […]
- PR Newswire•2 months ago
Accuray CyberKnife® System Treatment Delivery Times Up to 50 Percent Faster With Software Upgrade
SUNNYVALE, Calif., Dec. 6, 2018 /PRNewswire/ -- Accuray Incorporated (ARAY) announced today that the new release of its Accuray Precision® Treatment Planning System (TPS) with the CyberKnife® VOLO™ Optimizer will enable CyberKnife System customers to significantly improve operational efficiency by reducing both the time to create high quality treatment plans and the time it takes to deliver patient treatments.
- Simply Wall St.•2 months ago
How Should Investors React To Accuray Incorporated’s (NASDAQ:ARAY) CEO Pay?
Joshua Levine became the CEO of Accuray Incorporated (NASDAQ:ARAY) in 2012. This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. Next, we'll consider Read More...
- Zacks•2 months ago
Here's Why You Should Invest in Accuray (ARAY) Stock Now
Accuray's (ARAY) benefits from growing adoption of non-surgical treatment options among cancer patients and increasing demand for its latest offerings.
